Skip to main content


We're creating a new version of this page. See preview

  • Poster presentation
  • Open Access

2-tert-butyl-primaquine exhibit potent blood schizontocidal antimalarial activity via inhibition of heme crystallization

  • 1, 2,
  • 2, 3,
  • 4 and
  • 2
Malaria Journal20109 (Suppl 2) :P69

  • Published:


  • Infectious Disease
  • Plasmodium
  • Quinoline
  • Pharmacological Property
  • Major Improvement


Primaquine (PQ) is the only 8-quinolinamine available to treat the malarial parasites in the infections caused by Plasmodium vivax and P. ovale. PQ has broad range of antimalarial activities, including efficacy as a causal prophylactic, gametocytocide, and sporontocide. These encouraging pharmacological properties make PQ an ideal drug to emulate while designing new antimalarials with improved activities ([1]). The placement of a metabolically stable tert-butyl group at the C-2 position of a quinoline ring in PQ (2-tert-Butyl-Primaquine - BPQ) results in a tremendous improvement in blood schizontocidal antimalarial activity ([1, 2]). Because free heme released from hemoglobin catabolism in a malarial parasite is highly toxic, the parasite protects itself mainly by crystallization of heme into insoluble nontoxic hemozoin ([3]). In this study, we investigate the mechanism of blood schizontocidal activity of BPQ.


The ability of 2-tert-butylprimaquine to inhibit in vitro beta-hematin formation (see Table 1), to form a complex with heme with a stoichiometry of 1:1 (see Figure 1 and Figure 2), and to enhance heme-induced hemolysis (see Figure 3) were demonstrated.
Table 1

IC50 values for inhibition of P. falciparum growth and heme crystallization


IC50 (μM) for inhibition of


P. falciparum D6 clone growth

BH formation










*ND, not detected.

Figure 1
Figure 1

(abstract P69). Job plots of heme-CQ (closed circles), heme-PQ (closed triangles), and heme-BPQ (open circles) interaction. The total final combined concentration of heme and drug in the mixtures was constant at 10 μM in 40% aqueous DMSO. The pH and the temperature were constant at pH 7.4 and 25°C. The differential absorbance at 400 nm was recorded after incubation for 30 min. Values are the means ± standard errors of the means of three independent experiments. The results are reproducible.

Figure 2
Figure 2

(abstract P69). Hill plots of heme-CQ (closed circles) and heme-BPQ (open circles) association. The n values correspond to individual slopes. The n and Ka values for heme-CQ association were 1.09 and 3.24×105 M–1, respectively. The n and Ka values for heme-BPQ association were 1.07 and 0.61×105 M–1, respectively.

Figure 3
Figure 3

(abstract P69). Effects of heme-induced hemolysis by drugs. (A) Suspensions of erythrocytes were incubated in the presence of heme (final concentrations ranged from 0 to 20 μM) without (open circles) or with 10 μM CQ (closed circles), 10 μM PQ (open triangles), or 10μM BPQ (closed triangles). (B) Suspensions of erythrocytes were incubated in the presence of 10 μM of heme with various concentrations of the drug CQ (closed circles), PQ (open triangles), or BPQ (closed triangles). Error bars indicate standard deviations.


The results described herein indicate that a major improvement in the blood-schizontocidal antimalarial activity of 2-tert-butylprimaquine might be due to a disturbance of heme catabolism pathway in the malarial parasite.



Our sincere thanks to all members in Structural Biotechnology Laboratory, Department of Applied Biology, Kyoto Institute of Technology who have contributed to and worked on this study.

Authors’ Affiliations

Oxford University Clinical Research Unit, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam
Department of Applied Biology, Kyoto Institute of Technology, Kyoto 606-8585, Japan
Department of Immunogenetics, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki 852–8523, Japan
Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, Sector 67, S.A.S. Nagar, Punjab, 160 062, India


  1. Jain M, Vangapandu S, Sachdeva S, Singh S, Singh PP, Jena GB, Tikoo K, Ramarao P, Kaul CL, Jain R: Discovery of a bulky 2-tert-butyl group containing primaquine analogue that exhibits potent blood-schizontocidal antimalarial activities and complete elimination of methemoglobin toxicity. J Med Chem. 2004, 47: 285-287. 10.1021/jm0304562.View ArticlePubMedGoogle Scholar
  2. Jain M, Vangapandu S, Sachdeva S, Jain R: Synthesis and blood-schizontocidal antimalarial activities of 2-substituted/2,5-disubstituted-8-quinolinamines and some of their amino acid conjugates. Bioorg Med Chem. 2004, 12: 1003-1010. 10.1016/j.bmc.2003.12.029.View ArticlePubMedGoogle Scholar
  3. Egan TJ, Combrinck JM, Egan J, Hearne GR, Marques HM, Ntenteni S, Sewell BT, Smith PJ, Taylor D, van Schalkwyk DA, Walden JC: Fate of haem iron in the malaria parasite Plasmodium falciparum. Biochem J. 2002, 365: 343-347. 10.1042/BJ20020793.PubMed CentralView ArticlePubMedGoogle Scholar


© Thanh Thuy et al; licensee BioMed Central Ltd. 2010

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.